Prestige Consumer Healthcare Inc. (PBH)
| Market Cap | 2.78B |
| Revenue (ttm) | 1.09B |
| Net Income (ttm) | 205.38M |
| Shares Out | 50.28M |
| EPS (ttm) | 3.72 |
| PE Ratio | 14.86 |
| Forward PE | 13.50 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 319,462 |
| Open | 57.22 |
| Previous Close | 57.68 |
| Day's Range | 54.94 - 57.53 |
| 52-Week Range | 49.09 - 63.83 |
| Beta | 0.65 |
| Analysts | Buy |
| Price Target | 67.73 (+22.5%) |
| Earnings Date | May 5, 2022 |
About PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG ora...
Financial Performance
In 2021, PBH's revenue was $1.09 billion, an increase of 15.21% compared to the previous year's $943.37 million. Earnings were $205.38 million, an increase of 24.71%.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is 67.73, which is an increase of 22.50% from the latest price.
News
Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat
Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.
Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022
TARRYTOWN, N.Y., May 05, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2022.
What's in Store for Prestige Consumer (PBH) in Q4 Earnings?
Prestige Consumer's (PBH) fourth-quarter results are likely to reflect high demand for certain categories and gains from buyouts, while high costs are a concern.
Prestige Brands Getting Closer To Key Technical Measure
Prestige Brands shows improving price performance, earning an upgrade to its IBD Relative Strength Rating The post Prestige Brands Getting Closer To Key Technical Measure appeared first on Investor's Bu...
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Thursd...
Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids
Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.
Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce
Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.
What Makes Prestige Brands (PBH) a New Buy Stock
Prestige Brands (PBH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Prestige Consumer (PBH) Rises on Q3 Earnings Beat, Raised View
Prestige Consumer's (PBH) third-quarter results benefit from strong consumer demand and the strength in certain categories that were earlier affected by the pandemic. Management ups fiscal 2022 view.
Prestige Brands (PBH) Beats Q3 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results
TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021.
Factors to Know Ahead of Prestige Consumer (PBH) Q3 Earnings
Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.
Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results
TARRYTOWN, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 third quarter earnings release on Thursday, February 3,...
Should Value Investors Consider Prestige (PBH) Stock Now?
Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.
Prestige Consumer (PBH) Tops Q2 Earnings & Revenue Estimates
Prestige Consumer's (PBH) Q2 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.
Prestige Brands (PBH) Beats Q2 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 3.03% and 5.71%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
TARRYTOWN, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter ended September 30, 2021.
Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note
Prestige Consumer's (PBH) performance in the fiscal second quarter is likely to have gained from strong brand offerings, especially in healthcare, as well as growing e-commerce sales.
Prestige Brands (PBH) Earnings Expected to Grow: Should You Buy?
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 second quarter earnings release on Thursday, November 4...
LCUT vs. PBH: Which Stock Is the Better Value Option?
LCUT vs. PBH: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare (PBH) Sees Hammer Chart Pattern: Time to Buy?
Prestige Consumer Healthcare (PBH) has been struggling lately, but the selling pressure may be coming to an end soon.
Prestige Consumer (PBH) Surges More Than 65% YTD: Here's Why
Prestige Consumer (PBH) is consistently making multi-year e-commerce investments, which are yielding well. The company is focusing on the areas with significant prospects, such as healthcare.